Publications by authors named "Suzhong Zhang"
Article Synopsis
- Lebrikizumab treatment for uncontrolled asthma was evaluated in a systematic review and meta-analysis of five randomized controlled trials, showing consistent efficacy and safety results.
- The treatment significantly reduced asthma exacerbation rates and improved lung function (FEV1) compared to placebo, particularly in patients with high serum periostin levels.
- There was no significant difference in the incidence of adverse events between patients treated with lebrikizumab and those receiving a placebo.
In recent years, antitumor and antiviral effect of Caulis spatholobi becomes a hot topic of medical drug research. Experiment shows that the water extract of Caulis spatholobi compound 1802 showed the effect of inhibiting tumor growth, the difference was statistically significant (P<0.05); the rate of tumor inhibition was highest in the high dose group of compound 1802, which could reach 41.
View Article and Find Full Text PDF